Join our team! Oncology Physician Job Openings | CTCA
Registration is now open! Advances and Innovations in Interventional Gastroenterology and Gastrointestinal Cancer Care CME Program
Behind the FDA Approval: Subcutaneous Epcoritamab for R/R DLBCLMay 19th 2023
In an interview with Targeted Oncology, Tycel Phillips, MD, discussed what led to the FDA approval of subcutaneous epcoritamab for patients with relapsed/refractory diffuse large B-cell lymphoma and how it adds to the current treatment landscape.
How Newly-Approved Epcoritamab Will Impact R/R DLBCL TreatmentMay 19th 2023
Tycel Phillips, MD, discusses the impact of the recent approval of subcutaneous epcoritamab for the treatment of patients with relapsed/refractory diffuse large B-cell lymphoma after 2 or more lines of systemic therapy.
World Ovarian Cancer Day: Biomarkers Shape Treatment Decisions for Ovarian CancerMay 8th 2023
In an interview with Targeted Oncology for World Ovarian Cancer Day, Natalie Godbee, DO, discussed the current state of treatment for advanced ovarian cancer and how oncologists can get the best outcomes for their patients.
The Impact of Advancements on the Current and Future Multiple Myeloma LandscapeJanuary 4th 2023
In an interview with Targeted Oncology, Jeffrey R. Schriber, MD, discussed the impact of new advancements in the treatment of multiple myeloma, like the use of BiTE cells, on the current and future landscape for this patient population.
World Neuroendocrine Cancer Awareness Day: Therapeutic Options for Well-differentiated NETsNovember 10th 2022
Ajaz M. Khan, MD, MBA, CPE, a medical oncologist and chair of the CTCA Department of Medical Oncology, explores available treatments for patients with well-differentiated neuroendocrine tumors.
Gastroenterology’s Evolving Role in the Management of GI MalignanciesFebruary 9th 2022
In an interview with Targeted Oncology, Toufic Kachaamy, MD, discussed in detail the role of the gastroenterology community in staging, diagnosing, and managing gastrointestinal malignancies.
Surgery Remains the Gold Standard in Pancreatic Cancer TreatmentNovember 17th 2021
In an interview with Targeted Oncology, Katherine Poruk, MD, surgical oncologist, Cancer Treatment Centers of America, discussed the pancreatic treatment paradigm with an emphasis on the role of surgery.